NCT Number: NCT06398639
Phase: EARLY_PHASE1
Trial Summary: The goal of this clinical trial is to evaluate a screening method to detect clinically relevant prostate cancer. This clinical trial is using genetic data to determine a man’s risk of cancer, together – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): University of Alabama at Birmingham
Acronym: PRS
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives